Welcome to our dedicated page for Phinia SEC filings (Ticker: PHIN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
PHINIA Inc. filings document the reporting obligations of an operating industrial supplier focused on fuel systems, electrical systems and aftermarket solutions. The company’s 8-K reports furnish quarterly and annual operating results, financial condition updates and related earnings materials.
PHINIA’s regulatory record also includes proxy disclosures covering board matters, executive compensation, equity awards and shareholder voting items. Material-event filings document changes in the company’s certifying accountant, a settlement agreement, and tax matters tied to PHINIA’s July 2023 separation from BorgWarner.
WOOD ROGER reported acquisition or exercise transactions in this Form 4 filing.
PHINIA INC. director Roger Wood received an annual grant of 2,140 shares of restricted common stock, awarded at no cash cost as director compensation. These restricted shares will vest on May 22, 2027. After this grant, Wood directly holds a total of 22,063 common shares, including the 2,140 restricted shares.
Walsh Meggan M. reported acquisition or exercise transactions in this Form 4 filing.
PHINIA Inc. director Meggan M. Walsh reported an equity compensation award in the form of restricted stock. On May 22, 2026, she received a grant of 2,140 shares of common stock at no purchase price as an annual grant to independent directors. These restricted shares are scheduled to vest on May 22, 2027. Following this award, Walsh directly holds a total of 9,700 shares of PHINIA common stock, including the 2,140 restricted shares.
Chapin Samuel R. reported acquisition or exercise transactions in this Form 4 filing.
PHINIA Inc. director Samuel R. Chapin received an equity award of 2,140 shares of Common Stock as an annual grant of restricted stock to independent directors. The grant was made at no cash cost per share and will vest on May 22, 2027.
Following this award, Chapin directly holds 26,063 shares of PHINIA common stock, including the 2,140 shares of restricted stock covered by this grant.
PHINIA Inc. director Latondra Newton reported a new equity compensation award. She received 2,140 deferred restricted stock units (DRSUs), each economically equivalent to one share of PHINIA common stock. These DRSUs vest on May 22, 2027 and will convert into shares after her board service ends under the company’s Director Deferred Compensation Program and 2023 Stock Incentive Plan.
The filing also notes 3,367 DRSUs that have already vested and will settle upon her termination of board service, and shows 19,923 shares of common stock held directly after the reported transactions.
Norman Daun reported acquisition or exercise transactions in this Form 4 filing.
PHINIA Inc. director Norman Daun received equity-based compensation. On May 22, 2026, he was granted 2,140 shares of restricted common stock as an annual grant to independent directors, increasing his direct holdings to 22,063 shares. These restricted shares will vest on May 22, 2027.
He also received 836 deferred restricted stock units (DRSUs) in lieu of his annual non-employee director cash retainer at an economic equivalent of $74.80 per share. Each DRSU equals one share of PHINIA common stock, will vest on May 22, 2027, and will settle into shares upon his termination of board service under the company’s Director Deferred Compensation Program and 2023 Stock Incentive Plan.
Kendrick Robin reported acquisition or exercise transactions in this Form 4 filing.
PHINIA INC. director Robin Kendrick received an equity award of 2,140 shares of common stock as a grant on May 22, 2026. The award is in the form of restricted stock that will vest on May 22, 2027, reflecting routine compensation for an independent director.
After this grant, Kendrick directly holds 23,420 shares of PHINIA common stock, which include 2,140 restricted shares and 4,724 deferred restricted stock units that have vested and will settle upon termination of board service. An additional 15,794 shares are held indirectly through a trust.
Weerasinghe Rohan reported acquisition or exercise transactions in this Form 4 filing.
PHINIA Inc. director Rohan Weerasinghe received new equity-based compensation in the form of deferred restricted stock units (DRSUs). On May 22, 2026, he was granted 3,075 DRSUs at a reference value of $74.80 per unit and an additional 2,140 DRSUs.
Following these awards, his DRSU balance reported in this filing is 5,215 units, all tied to PHINIA common stock. Footnotes note that 8,551 DRSUs have already vested and will settle in shares when his board service ends, and that the new DRSUs were elected in lieu of his annual equity grant and cash retainer, vesting on May 22, 2027.
PHINIA INC. director Newton Latondra exercised deferred equity awards into common shares. On May 21, 2026, Latondra converted 3,367 Deferred Restricted Stock Units (DRSUs), which are each economically equivalent to one share of PHINIA common stock, into 3,367 shares of common stock at a price of $0.00 per share. Following this derivative exercise, Latondra directly holds 19,923 shares of PHINIA common stock. The filing describes this as an exercise or conversion of a derivative security rather than an open-market purchase or sale, and there are no remaining shares reported under this specific DRSU grant after the transaction.
PHINIA INC. director Kendrick Robin reported routine equity compensation activity involving deferred restricted stock units and common stock. The filing shows that Robin exercised or converted 4,724 Deferred Restricted Stock Units (DRSUs), each described as the economic equivalent of one share of PHINIA common stock.
Following these transactions, Robin is shown holding 21,280 shares of common stock directly and 15,794 shares indirectly through a trust. Footnotes explain that 4,724 DRSUs have vested and will settle into the same number of common shares when Robin’s board service ends, under PHINIA’s Director Deferred Compensation Program and 2023 Stock Incentive Plan.
PHINIA INC. director Rohan Weerasinghe reported an equity compensation-related transaction involving deferred units and common stock. On May 21, 2026, he acquired 8,551 shares of common stock at a stated price of $0.00 per share through the exercise or conversion of deferred restricted stock units (DRSUs).
Following the transaction, his direct holdings of PHINIA common stock increased to 31,237 shares. In addition, 12 shares are held indirectly in a managed account. The filing characterizes the DRSUs as the economic equivalent of common stock that vest and settle in shares in connection with his service as a director under the company’s deferred compensation and stock incentive plans.